Diligence memo · auto-generated · as of July 2, 2026

Iscience Interventional Corp

Iscience Interventional Corp looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Iscience Interventional Corp operates in Other Health Care, based in Menlo Park.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Iscience Interventional Corp has raised $40M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $21M on 2009-03-31.

Most recent recorded round closed around 2012-01-27.

Valuation (modeled)modeled

Provath models Iscience Interventional Corp at approximately $61M (range $6.5M–$235M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.14× the median modeled value of Series B Other Health Care companies in 2010–2012 (50 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 7 months.

Last raise 14.4 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.1× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 91% of Other Health Care peers (5377 compared).

Modeled value ranks above 70% of those peers.

Closest niche peers: Cell MDX, LLC, OptiMedica Corp, Riverchase Holdings Mso, Llc, CDRT Holding Corp, Pivot Medical Inc.

Peoplefiled

15 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.